SEC Form 4 · accession 0001209191-16-153414
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel C Barrish
Officer — Chief Scientific Officer
Period of report
Dec 2, 2016
Accepted (ET)
Dec 5, 2016 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 2, 2016 | P | 2,500 | $4.06 | A | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.